Pharma Journalist -

SiO2 Medical Products, Inc., a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc., a U.S.-based…
Read More...

Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...

Zoetis Inc. and Nexvet Biopharma plc announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)…
Read More...

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C. The company said the approval of Maviret was…
Read More...

Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. and a global holistic healthcare company dedicated to bettering the health of people worldwide,…
Read More...

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that it has entered into a global strategic license with NantCell,…
Read More...

Baxter International Inc., a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, today announced it has received approval from the…
Read More...

Jazz Pharmaceuticals plc announced that it has entered into a license agreement with XL-protein GmbH ("XLp") for the rights to develop, manufacture and commercialize products using…
Read More...

AstraZeneca and Merck & Co., Inc., known as MSD outside of the United States and Canada, announced that they have entered a global strategic oncology collaboration to co-develop and…
Read More...